Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Aug;70(8):3026-3032.
doi: 10.4103/ijo.IJO_3198_21.

The effectiveness of laser vitreolysis for vitreous floaters in posterior vitreous detachment

Affiliations

The effectiveness of laser vitreolysis for vitreous floaters in posterior vitreous detachment

Wan Ni Goh et al. Indian J Ophthalmol. 2022 Aug.

Abstract

Purpose: To determine the effectiveness of laser vitreolysis in terms of contrast sensitivity function (CSF) and vision-related quality of life (VRQol) for symptomatic floaters due to posterior vitreous detachment (PVD).

Materials: This is an interventional study that involved 57 eyes of 45 patients with symptomatic floaters for more than 3 months. Patients underwent one to three sessions of vitreolysis via Neodymiun-doped Yttrium Aluminum Garnet (Nd:YAG) laser. We examined the CSF using the computer programs Freiburg Acuity and Contrast Test (FrACT) and VRQoL survey using the National Eye Institute Visual Function Questionnaire-25 (NEI VFQ-25) before, and 1 month after, vitreolysis.

Results: Twelve patients had both eyes lasered and 33 patients had one eye lasered. The mean CSF improved from 3.20 ± 0.85%W to 2.64 ± 0.63%W 1 month after vitreolysis. Each use of the laser showed a significant mean difference in CSF (%W) as analyzed by paired t-test before and after the first laser (0.29 ± 0.49%W [P ≤ 0.001]); after the first and second laser (0.35 ± 0.53%W [P = 0.01]); and after second and third laser (0.21 ± 0.31%W [P = 0.02]). There was improvement in the median of four subscales in NEI VFQ-25 scores post treatment: general vision (z = -3.30, P = 0.001), near activity (z = 3.396, P = 0.001, distance activity (z = -2.788, P = 0.005), and mental health (z = -2.219, P = 0.026). The mean scores increased to 79.55 ± 9.45 from the baseline 75.06 ± 9.69 (P ≤ 0.001). No adverse events were recorded 1 month after the laser treatments.

Conclusion: Vitreolysis by Nd:YAG laser improved the CFS and VRQoL in symptomatic PVD patients.

Keywords: Contrast sensitivity function; floaters; laser vitreolysis; neodymiun-doped yttrium aluminum garnet laser; posterior vitreous detachment.

PubMed Disclaimer

Conflict of interest statement

None

Figures

Figure 1
Figure 1
Consort flow diagram
Figure 2
Figure 2
Fundus photography before and after laser vitreolysis. (Left) Black arrow shows a single small clump floater in front of the optic disc; (Right) White arrow shows minimal remnant of vitreous opacity left after vitreolysis. Patient was asymptomatic after one session of laser so no further treatment was given

Similar articles

References

    1. Huang LC, Yee KMP, Wa CA, Nguyen JN, Sadun AA, Sebag J. V. B.8. Vitreous Floaters and Vision:Current Concepts and Management Paradigms. 2014:771–88. 10.1007/978-1-4939-1086-1_45.
    1. Shen Z, Duan X, Wang F, Wang N, Peng Y, Liu DTL, et al. Prevalence and risk factors of posterior vitreous detachment in a Chinese adult population:The Handan eye study. BMC Ophthalmol. 2013;13:1–6. doi:10.1186/1471-2415-13-33. - PMC - PubMed
    1. Webb BF, Webb JR, Mary CS, North CS. Prevalence of vitreous floaters in a community sample of smartphone users. Int J Ophthalmol. 2013;6:402–5. - PMC - PubMed
    1. Kim Y-K, Moon SY, Yim KM, Seong SJ, Hwang JY, Park SP. Psychological distress in patients with symptomatic vitreous floaters. J Ophthalmol. 2017:1–9. doi:10.1155/2017/3191576. - PMC - PubMed
    1. Mamou J, Wa CA, Yee KMP, Silverman RH, Ketterling JA, Sadun AA, et al. Ultrasound-based quantification of vitreous floaters correlates with contrast sensitivity and quality of life. Invest Ophthalmol Vis Sci. 2015;56:1611–7. - PMC - PubMed